BIOVIE INC.

Nasdaq:BIVINasdaq:BIVIW

Pharmaceutical Preparations·CARSON CITY, NV

CEO

Do Cuong V

CFO

Kim Joanne Wendy

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/6/26	→
10-Q	Q3 2025	9/30/25	11/10/25	→
10-K	FY 2025	6/30/25	8/15/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-Q	Q4 2024	12/31/24	2/11/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

News (8-K)

80 shown

Filed	Type	Description
11/13/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/12/25	Vote	Submission of Matters to a Vote of Security Holders	→
8/11/25	Agreement	Entry into a Material Definitive Agreement	→
7/23/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/27/25	Other	Material Modification to Rights of Security Holders	→
6/24/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/25/25	S-8	S-8	→
10/6/25	424B3	424B3 PROSPECTUS SUPPLEMENT NO.1	→
8/8/25	424B5	424B5	→
8/4/25	S-1/A	FORM S-1 AMENDMENT NO. 3	→
7/22/25	S-1/A	FORM S-1 AMENDMENT NO. 2	→
7/11/25	S-1/A	FORM S-1 AMENDMENT NO. 1	→
↓

Filing History(479 filings)

TypeDateAccessionPeriodSize

10-Q

Feb 6, 2026

0001520138-26-000052FORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2025

Dec 31, 2025

3.7 MB

Jan 9, 2026

0001520138-26-000024

Jan 5, 2026

5.4 KB

Jan 9, 2026

0001520138-26-000023

Jan 5, 2026

5.4 KB

Jan 9, 2026

0001520138-26-000022

Jan 5, 2026

7.7 KB

Jan 9, 2026

0001520138-26-000021

Jan 5, 2026

5.7 KB

Jan 9, 2026

0001520138-26-000020

Jan 5, 2026

216.5 KB

Jan 9, 2026

0001520138-26-000019

Jan 5, 2026

5.5 KB

Jan 9, 2026

0001520138-26-000018

Jan 5, 2026

5.5 KB

Jan 9, 2026

0001520138-26-000017

Jan 5, 2026

7.7 KB

S-8

Nov 25, 2025

0001520138-25-000371FORM S-8

—

247.1 KB

EFFECT

Nov 18, 2025

9999999995-25-003311

—

1.8 KB

8-K

Nov 13, 2025

0001520138-25-000352CURRENT REPORT

Nov 10, 2025

232.3 KB

8-K

Nov 12, 2025

0001520138-25-000347CURRENT REPORT

Nov 10, 2025

191.4 KB

10-Q

Nov 10, 2025

0001520138-25-000343FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2025

Sep 30, 2025

3.4 MB

Oct 28, 2025

0001520138-25-000327

Jul 17, 2025

8.4 KB

Oct 27, 2025

0001520138-25-000326

Jul 17, 2025

8.5 KB

POS AM

Oct 6, 2025

0001520138-25-000294POS AM

—

581.5 KB

POS EX

Oct 6, 2025

0001520138-25-000293POS EX

—

240.9 KB

424B3

Oct 6, 2025

0001520138-25-000292424B3 PROSPECTUS SUPPLEMENT NO.1

—

772.5 KB

DEF 14A

Sep 25, 2025

0001520138-25-000287DEF 14A

Sep 25, 2025

711.2 KB

10-K

Aug 15, 2025

0001520138-25-000268FORM 10-K

Jun 30, 2025

5.6 MB

Aug 13, 2025

0001520138-25-000251

Aug 7, 2025

7.4 KB

8-K

Aug 11, 2025

0001520138-25-000249CURRENT REPORT

Aug 7, 2025

1.3 MB

424B5

Aug 8, 2025

0001520138-25-000247424B5

—

8.1 MB

EFFECT

Aug 7, 2025

9999999995-25-002514

—

1.8 KB

25 filings shown

BIOVIE INC.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(479 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
9/25/25	DEF 14A	DEF 14A	→
6/2/25	DEF 14A	DEF 14A	→
5/8/25	PRE 14A	PRE 14C	→
5/7/25	PRE 14C	PRE 14C	→
10/22/24	DEFA14A	DEFA14A	→
9/27/24	DEF 14A	PRE 14A	→
↓

Filed	Form	Description
1/9/26	4	4	→
1/9/26	4	4	→
1/9/26	4	4	→
1/9/26	4	4	→
1/9/26	4	4	→
1/9/26	4	4	→
↓

Filed	Form	Description
11/18/25	EFFECT	EFFECT	→
10/6/25	POS AM	POS AM	→
10/6/25	POS EX	POS EX	→
8/7/25	EFFECT	EFFECT	→
8/7/25	CERT	CERT	→
8/7/25	8-A12B	FORM 8-A12B	→
↓